Guanacastepene was originally isolated from a fungus growing
on a tree in Costa Rica in the year 2000 and was reported to be
an antibiotic active against methicillin-resistant Staphylococcus
and vancomycin-resistant Enteroccus. Since drug-resistant
bacteria have become a major problem, guanacastepene attracted
great interest. Since guanacastepene is not readily available
from natural sources, there was thus a great interest in many
laboratories in the synthesis of this natural product so that
the biology of guanacastepene could be further studied. Our 2001
Organic Letters paper
describes the first report of a route to a portion of the
skeleton of guanacastepene. The synthesis of guanacastepene has
since been completed by both Danishefsky in 2002 and by our
laboratory in 2003 and now numerous other laboratories are
working on this target.
Does
it describe a new discovery or new methodology that is useful to
others?
Guanacastepene has an unusual tricyclic-fused core. The
chemistry in our paper describes a novel and practical route to
the central seven-membered ring and a very unusual new route to
the cyclopentanone.
Could
you summarize the significance of your paper in layman’s terms?
Natural products often have interesting biological properties
that are of interest for drug development. However, their
availability from natural sources may be very limited (as in
this case) so that total synthesis in the laboratory is the only
way to make enough material for further biological evaluation.
However, the structures of natural products, such as
guanacastepene, are often very different than those of man-made
compounds, and new techniques have to be invented and perfected
to manufacture these compounds in the laboratory. This paper
describes several new methods that are useful for the synthesis
of the guanacastepene family of natural products so that their
biological activity can be fully evaluated.
How
did you become involved in the research?
We became interested in this research because it offered an
opportunity to exploit and further develop a cyclopentanone
synthesis, which we had first developed several years earlier.
Barry Snider
Breskin Professor of Organic Chemistry
Department of Chemistry
Brandeis University
Waltham, MA, USA